50+ years of scientific excellence

For more than 50 years, we’ve asked, “What if we tried this?” That curiosity, and the willingness to push boundaries, is part of how we work.

Specialty and central lab solutions for clinical trials, backed by scientific expertise and a global network.
We provide specialty lab solutions to sponsors worldwide, customized to your program and grounded in science, to help accelerate your drug development.


For more than 50 years, we’ve asked, “What if we tried this?” That curiosity, and the willingness to push boundaries, is part of how we work.

Specialty expertise and central lab scale come together in one workflow, from the most complex assays to global trial coordination, to help your studies move faster.

Our network spans 42 laboratories across five continents, and every sample still gets individual attention.

We work to one global standard across our labs, from Stockholm to São Paulo, so you get consistent quality wherever your trial takes you.




Choosing the right assay, partner, and approach shapes the quality of your data. Our specialty services bring all three together.
Early scientific insights help you strengthen your protocol. We apply our knowledge of circulating biomarkers to support integrated clinical trial delivery and diagnostic development worldwide.

Bring your research questions to our immunoassay team. We support work across efficacy, safety, immunogenicity, pharmacokinetics, pathogenicity, passive immunization, antiviral therapy and prophylaxis, drug delivery, and resistance mutants.

From next-generation sequencing (NGS) to immune repertoire sequencing and DNA/RNA analysis, our genomics team brings more than 30 years of sequencing experience to your research.

Our scientific team works with you to design and develop the flow cytometry panels your research needs. Get in touch to see how flow cytometry can strengthen your study.

We tailor our lab solutions to the science of each therapeutic area, from oncology to rare and infectious diseases, to help turn your research into treatments for patients.
Responsible science means more than good results. Across our laboratory network, we build ethical practices, environmental stewardship, and community impact into how we work.

Our whitepapers, case studies, and publications draw on the trials and challenges our scientists work with every day.

Our global team shares perspectives on every stage of clinical trial development, from assay design to sample logistics.
Discover how to validate tumor antigen expression with IHC and avoid the HER2-low and PD-L1 pitfalls that skew patient selection and trial outcomes.

Up to 80% of relapses after targeted therapy are driven by pre-existing resistant subclones. Discover how deep NGS enables their detection and supports effective tracking of tumor evolution and resistance.

In this edition of the Flow Matters blog, we’re diving into how flow cytometry is transforming virology and vaccine research and how new technological advances are giving researchers an unprecedented view of the immune system in action.

Learn how ADC trials are advancing breast and ovarian cancer treatment while addressing resistance, biomarker, and trial design challenges.
